- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 454
HubSpot sets range for IPO, aiming for $120m
HubSpot, which is backed by investors including Google and Salesforce, plans to float at a price between $19 and $21 a share.
Oct 2, 2014Rocket fails to take off after $1.8bn IPO
Rocket Internet followed compatriot Zalando on to the Frankfurt Stock Exchange today at the top of its range, only to see its shares subsequently fall.
Oct 2, 2014Kakao and Daum close $9.4bn merger
Tencent and CyberAgent both recorded hefty exits as online messaging service Kakao joined forces with internet portal Daum in a reverse merger.
Oct 1, 2014Zalando goes public in $664m IPO
The online fashion retailer, backed by Anders Holch Povlsen, Holtzbrinck and Tengelmann, floated near the top of its range and could raise up to $765m before the IPO closes.
Oct 1, 2014Corporates exit Alios BioPharma in $1.75bn acquisition
Novo, Roche, GlaxoSmithKline and Novartis, all of which participated in a $41m round for Alios in April, exited the pharmaceutical company, which was bought by Johnson & Johnson.
Sep 30, 2014Vitae aims to improve its life with $55m IPO
The pharmaceutical company, backed by Allergan and Boehringer Ingelheim, raised the cash after $109m of equity funding.
Sep 30, 2014Millennial comes for Nexage in $107m deal
Hearst and SingTel both exited after the mobile advertising platform was acquired by Millennial Media for $107.5m.
Sep 29, 2014Alkermes gets $37m exit from Civitas
Parkinson's disease treatment company Civitas has been bought by Acorda for $525m, weeks after it raised a $55m series C round and filed for an IPO.
Sep 27, 2014WPP exits after Visible Technologies seen by buyers
WPP-backed analytics software company Visible Technologies has been acquired by public relations technology firms Vocus and Cision after raising $30m in funding.
Sep 26, 2014Molecular Partners thinks bigger for $134m IPO
The Johnson & Johnson-backed Switzerland-based protein developer is looking to go public after raising almost $60m in equity funding.
Sep 24, 2014About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


